Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Micronized Progesterone for Perimenopausal Vasomotor Symptoms
NCT01464697Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Oct 2011
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of progesterone in vasomotor symptoms, sponsored by University of British Columbia. Started Oct 2011; status: completed.
02
Drugs
progesterone
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT01464697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464697.